Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (4677)

« Back to Publications

Effect of an osteoporotic fracture prevention program on fracture incidence in routine care: a cluster-randomized trial

Rapp K. et al, (2022), Bmc medicine, 20

Factors associated with reporting of the Prevention of Falls Network Europe (ProFaNE) core outcome set domains in randomized trials on falls in older people: a citation analysis and correlational study

Korall AMB. et al, (2022), Trials, 23

Progressive exercise versus best practice advice for adults aged 50 years or over after ankle fracture: the AFTER pilot randomised controlled trial.

Keene DJ. et al, (2022), Bmj open, 12

The top 10 research priorities in psoriatic arthritis: a James Lind Alliance Priority Setting Partnership

HAILEY L. et al, (2022), Rheumatology

The top 10 research priorities in psoriatic arthritis: a James Lind Alliance Priority Setting Partnership

HAILEY L. et al, (2022), Rheumatology

FUTURE-GB: functional and ultrasound-guided resection of glioblastoma - a two-stage randomised control trial.

Plaha P. et al, (2022), Bmj open, 12

Current issues and future considerations for the wider implementation of robotic-assisted surgery: a qualitative study.

Lawrie L. et al, (2022), Bmj open, 12

Treat-to-target in rheumatoid arthritis: a real-world study of the application and impact of treat-to-target within the wider context of patient management, patient centricity, and advanced therapy use in Europe

TAYLOR PC. et al, (2022), Rmd open

Bimekizumab in patients with active psoriatic arthritis and prior inadequate response or intolerance to tumour necrosis factor inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE)

Merola JF. et al, (2022), The lancet

Bimekizumab in patients with psoriatic arthritis, naïve to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL)

McInnes IB. et al, (2022), The lancet

Inclusion of progression criteria in external randomised pilot trials: a cross-sectional study of funding applications submitted to the NIHR Research for Patient Benefit Programme.

Mellor K. et al, (2022), Trials, 23

The impact of COVID-19 on care of early inflammatory arthritis in the UK.

MacPhie E. and Coates LC., (2022), Lancet rheumatol

Cost-utility analysis of surgical fixation with Kirschner wire versus casting after fracture of the distal radius : a health economic evaluation of the DRAFFT2 trial.

Png ME. et al, (2022), Bone joint j, 104-B, 1225 - 1233

Management of Dactylitis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations

Palominos PE. et al, (2022), The journal of rheumatology, jrheum.220311 - jrheum.220311

Outcome measures in psoriatic arthritis: Where next?

Hackett S. and Coates LC., (2022), Musculoskeletal care, 20 Suppl 1, S22 - S31

Evaluation of cultural competency in a South African cluster randomised controlled trial: lessons learned for trial reporting standards.

Siegfried NL. et al, (2022), Trials, 23

Physical Activity and Health-Related Quality of Life of Patients With Chronic Pain After Total Knee Replacement: Evidence From a Physiotherapy Randomised Controlled Trial

Fabiano G. et al, (2022)

Prologue: Evidence Informing the GRAPPA 2021 Treatment Recommendations, by Domain.

Soriano ER. et al, (2022), J rheumatol

Author Correction: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021

Coates LC. et al, (2022), Nature reviews rheumatology

BJJ-2022-0653.R1 Platelet rich plasma injection for acute Achilles tendon rupture: Two-year follow-up of the PATH-2 randomised, placebo-controlled, superiority trial

KEENE D. et al, (2022), Bone and joint journal

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?